Living Organisations

The family called it “the second shift”: the hours spent reconciling what different services believed about the same person. Emerging AI, institutional and societal change creates a material need to understand and govern living organisations.

In United Kingdom, Nala's team at a regional health service had been asked to explore living Organisations. The immediate pressure was practical: current systems address movement from fixed hierarchies toward networked, agentic, adaptive and ecosystem-based organisations unevenly. For Living Organisations, definitions, measures, safeguards and accountable implementation pathways remain fragmented or unvalidated. People could see activity, outputs and confident recommendations, but those signals did not establish that capability, safety or agency had improved.

Nala resisted turning the scenario into a success story too early. As a clinical researcher, Nala knew that a memorable example can clarify a research problem, but it cannot validate a causal claim. The team therefore framed one answerable question: Under which conditions does living organisations improve human and system outcomes, how do effects vary across populations and contexts, and what safeguards prevent dependency, exclusion, distortion or loss of agency? The story gave the work human stakes; the question gave it a boundary.

The working hypothesis was specific enough to fail: A transparent, participatory and human-directed approach to living organisations, with explicit safeguards and longitudinal evaluation, will improve decision speed; accountability; adaptability; memory retention; coordination cost; employee agency; outcome quality compared with opaque, automation-first or short-term approaches. That wording changed the conversation. Instead of asking whether the idea sounded beneficial, the team had to compare conditions, define what improvement meant, and decide what evidence would count against the intervention. They also had to test whether a short-term gain concealed dependence, reduced understanding, new exclusion or a difficult handback when assistance disappeared.

The proposed study centred on organisational network analysis, operating-model experiments, decision tracing, agent workflow trials. The design varied Independent variables: intervention design, AI involvement, human control, duration and observed decision speed, accountability, adaptability, memory retention, coordination cost. Subgroup and accessibility analysis were not treated as optional additions. A result that helped an average participant while predictably harming a smaller group would not satisfy the programme's definition of success.

During the imagined pilot, the most useful moment was not a dramatic breakthrough. It was a disagreement. One participant completed the task faster but reported less control; another moved more slowly yet retained the process after support was withdrawn. Nala asked the team to record both observations without choosing a preferred ending. They were scenario prompts, not findings, and they exposed why performance alone could not carry the evaluation.

The team built recovery into the protocol. Participants could challenge a recommendation, inspect relevant reasoning, pause the intervention and resume unaided. Failure scenarios tested changed conditions and incomplete information. Delayed follow-up asked whether any advantage persisted and whether people could still act independently. This made the study less theatrical and more useful: the system had to support correction and handback, not merely produce an impressive first result.

The unknowns remained visible: Effect size, causal mechanism, long-term adaptation, cultural and regional variation, implementation cost, institutional incentives, cross-context transfer. The principal risks included loss of agency, inequity, cultural distortion, dependency. None could be resolved by the narrative itself. They required sourced literature, approved ethics and accessibility review, a pre-registered protocol, traceable evidence and reproducible analysis.

If the hypothesis is supported, the value could extend beyond one pilot in health and care. Target: improve decision speed; accountability; adaptability; memory retention; coordination cost; employee agency; outcome quality; subtopic-specific outcomes for living organisations; equity; unintended effects; recovery or adaptation time while preserving dignity, agency, rights, inclusion, cultural integrity and long-term human capability. The same evidence could inform product requirements, assurance services, training, procurement criteria and policy guidance. If the hypothesis is not supported, that result would still be valuable by preventing a weak approach from scaling behind attractive claims.

At the closing review, Nala replaced the original programme claim with a more honest sentence: “We know what must be tested next.” An integrated, testable assurance and implementation protocol for living organisations linking human outcomes, governance, equity, long-term adaptation and recovery. For the people represented by the story, progress would not mean a system doing more. It would mean a person remaining more capable when the system stepped back.